CRL
Charles River Laboratories International Inc.
Company Overview
| Mkt Cap | $8.22B | Price | $180.07 |
| Volume | 950.25K | Change | +0.54% |
| P/E Ratio | 370.2 | Open | $178.39 |
| Revenue | $4.0B | Prev Close | $179.11 |
| Net Income | $22.2M | 52W Range | $91.86 - $230.02 |
| Div Yield | N/A | Target | $187.15 |
| Overall | 59 | Value | 60 |
| Quality | -- | Technical | 58 |
No chart data available
Stock Overview
Updated DailyCharles River Laboratories International Inc. (CRL) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $180.07 with a market capitalization of $8.22 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CRL with a volume of 950K shares. The stock opened down 0.40% from yesterday's close of $179.11. Current analyst estimates project earnings of $10.17 per share for this year, with next year targeting $10.71.
CRL demonstrates neutral technical outlook based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including RGEN, TMO, SCYX.
Key investment considerations for CRL include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 3.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:47 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRL | $180.07 | +0.5% | 950.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Charles River Laboratories International Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW